Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06880302 · ClinicalTrials.gov registry record

Male Infertility and Assisted Reproductive Technologies Research Biobank

A clinical trial of Infertility (IVF Patients) and Male Infertility, sponsored by Reproductive Medicine Associates of New Jersey.

Recruiting
Registry status
1,000
Enrollment target
1
Study location

NCT06880302: Recruiting study of Infertility (IVF Patients) and Male Infertility, sponsored by Reproductive Medicine Associates of New Jersey.

NCT06880302 is a study of Infertility (IVF Patients) and Male Infertility that is actively recruiting participants, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 1,000 participants, above the 368-participant average among 9 other Infertility (IVF Patients) trials with a reported enrollment target (172% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06880302, a study of Infertility (IVF Patients) and Male Infertility, is actively recruiting participants, sponsored by Reproductive Medicine Associates of New Jersey.

RECRUITING
Registry status
1,000 participants
Enrollment target
1
Study location

Study Summary

The objective of this research is to build a biobank of biological male specimens used for diagnostics and treatment of infertility or assisted reproductive technologies (ART).

Primary Outcome

The purpose of this study is to create a biobank of male biological specimens

Study Locations (1)

New Jersey

  • RMANJ - Basking Ridge

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2025-03-04
Est. Completion 2032-12

What NCT06880302 shows while recruiting

NCT06880302 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 368-participant average among 9 other Infertility (IVF Patients) trials with a reported enrollment target (172% higher).

The record links to 2 conditions, with Infertility (IVF Patients) appearing as the primary indexed condition, and to 0 interventions.

NCT06880302 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT06880302 about?

NCT06880302 is a clinical study titled "Male Infertility and Assisted Reproductive Technologies Research Biobank". The objective of this research is to build a biobank of biological male specimens used for diagnostics and treatment of infertility or assisted reproductive technologies (ART).

What is the current status of trial NCT06880302?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2025-03-04. Estimated completion is 2032-12.

What conditions does trial NCT06880302 study?

This clinical trial studies the following conditions: Infertility (IVF Patients), Male Infertility.

Who is sponsoring clinical trial NCT06880302?

This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06880302 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infertility (IVF Patients)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06880302's enrollment target sits among peer trials

1,000 2nd of 9 the highest of 9 other Infertility (IVF Patients) trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Infertility (IVF Patients) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06880302, the US trial registry maintained by the National Library of Medicine. NCT06880302 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.